Interview with Natsu Yorita - Chiyu Sawaizumi / Cure Fontaine ~~~ Q: What was your reaction when you learned that you got the role in the Pretty Cure series? ►My manager suddenly called me at the agency and announced to my surprise that I had gotten the part. When I heard the news, I was thrilled. Participating in the auditions for the Precure series was already the fulfillment of a dream for me. So getting the part was more than incredible for me. I still have no words to express how happy I am to have been chosen. I’m going to be in a series I’ve loved for years and join the ones I’ve long admired as Pretty Cure. I will strive to be worthy of this opportunity to share with you my love of the series. Q: What are the qualities of the heroine Cure Fontaine (Chiyu Sawaizumi)? ►My first impression was that she is an intelligent, responsible and caring girl. When I play the role of Chiyu, I try to express this feeling of righteousness, but appearances can be deceiving. I will do my best to convey its character in serious moments as well as in more offbeat moments. Q: What are the qualities of the Pretty Cure series for you? ►Even if there are too many to name them all, for me, one of the main qualities of the series is that it gives courage. Not only do heroines face enemies, they must also grow up, find a dream, follow their passions and juggle all the elements of daily life without ever giving up. By watching their stories, their determination is communicative and they push us to surpass ourselves, to find the courage to go forward. Without forgetting that they are pretty! The Pretty Cures couldn't give us as much energy if they weren't so adorable. Q: Do you have a message for the public? ►I am happy and honored to have been chosen to play in Healin’Good ♡ Precure. I hope you enjoy the story and that your heart will beat in unison with us. I will dedicate myself body and soul to presenting you the best Cure Fontaine possible alongside my new friends and my partner Pegitan. Thank you for all your invaluable support.
